Paul Offit, MD, director, Vaccine Education Center, and professor of pediatrics, Children’s Hospital of Philadelphia; professor of vaccinology, Perelman School of Medicine, University of Pennsylvania.
Naor Bar-Zeev, PhD, associate professor of international health and vaccinology and deputy director, International Vaccine Access Center, Johns Hopkins Bloomberg School of Public Health, Baltimore.
JAMA Live Stream: Dec. 2, 2020.
American Nurses Foundation: “Pulse of the Nation’s Nurses COVID-19 Survey Series: COVID-19 Vaccine.”
CDC: “Understanding How COVID-19 Vaccines Work,” “Ensuring COVID-19 Vaccines Work,” “Meeting of the Advisory Committee on Immunization Practices (ACIP) November 23.”
CDC, ACIP COVID-19 Work Group: “Phased Allocation of COVID-19 Vaccines.”
Statista.com: “The Cost Per Jab of Covid-19 Vaccine Candidates.”
FDA: “Coronavirus (COVID-19) Update: FDA Takes Action to Help Facilitate Timely Development of Safe, Effective COVID-19 Vaccines.”
AstraZeneca: “COVID-19 vaccine AZD1222 is better tolerated in older adults than younger adults with similar immune responses across all age groups,” “AZD1222 vaccine met primary efficacy endpoint in preventing COVID-19.”
The Lancet: “Safety and immunogenicity of ChAdOx1nCoV-19 in a prime-boost regimen in young and old adults (COV002) in a single-blind, randomized, controlled, phase 2/3 trial.”
Good Morning America: Interview with Anthony Fauci, MD.
Pfizer: “Pfizer and BioNtech Conclude Phase 3 Study of COVID-19 Vaccine Candidate, Meeting All Primary Efficacy Endpoints.”
Moderna: “Moderna’s COVID-19 Vaccine Candidate Meets its Primary Efficacy Endpoint in the First Interim Analysis of the Phase 3 COVE Study.”
BMJ.com: “Covid-19: Moderna vaccine is nearly 95% effective, trial involving high risk and elderly people shows.”Â
USA Today: “Are there side effects to a COVID-19 vaccine? What are the ‘ingredients’? The cost? Answers to your vaccine questions.”